Grunden JW and Fisher KA |
Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. |
1997 Jul-Aug |
Ann Pharmacother |
pmid:9220046
|
Tartaglione T |
Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. |
1997 Jul-Aug |
Clin Ther |
pmid:9377608
|
Nawarskas JJ et al. |
Digoxin toxicity secondary to clarithromycin therapy. |
1997 Jul-Aug |
Ann Pharmacother |
pmid:9220047
|
al-Humayyd MS |
Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat. |
1997 Mar-Apr |
Chemotherapy |
pmid:9084915
|
Svoboda P et al. |
Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. |
1997 May-Jun |
Hepatogastroenterology |
pmid:9222709
|
Best LM et al. |
Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218854
|
O'Brien B et al. |
Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218858
|
Guerriero SE et al. |
Two cases of clarithromycin-induced digoxin toxicity. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324195
|
Anzueto A et al. |
Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group. |
1997 Sep-Oct |
Clin Ther |
pmid:9385486
|
Highleyman L |
FDA issues Hismanal warning. Food and Drug Administration. |
1998 |
BETA |
pmid:11365263
|
Elliott RL et al. |
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. |
1998 |
J. Med. Chem. |
pmid:9572890
|
Griesgraber G et al. |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. |
1998 |
J. Med. Chem. |
pmid:9572891
|
Al-Sibai MB et al. |
Ocular penetration of oral clarithromycin in humans. |
1998 |
J Ocul Pharmacol Ther |
pmid:9867340
|
Wallace RJ and Brown BA |
Catheter sepsis due to Mycobacterium chelonae. |
1998 |
J. Clin. Microbiol. |
pmid:9867491
|
Shafran SD et al. |
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. |
1998 |
Clin. Infect. Dis. |
pmid:9868650
|
Kondoh K and Hashiba M |
[Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. |
1998 |
Nippon Jibiinkoka Gakkai Kaiho |
pmid:9493436
|
Saika T et al. |
[A mechanism of clarithromycin resistance in Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9796191
|
Abouesh A and Hobbs WR |
Clarithromycin-induced mania. |
1998 |
Am J Psychiatry |
pmid:9812131
|
Pipkin GA et al. |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768524
|
Louw JA et al. |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768531
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|
Laine L et al. |
Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768532
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Mukunda BN et al. |
Clarithromycin therapy for bacillary peliosis did not prevent bacillary angiomatosis. |
1998 |
Clin. Infect. Dis. |
pmid:9770180
|
Stack WA et al. |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. |
1998 |
Am. J. Gastroenterol. |
pmid:9772054
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Fennerty MB |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance. |
1998 |
Am. J. Gastroenterol. |
pmid:9448162
|
Forné M et al. |
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. |
1998 |
Am. J. Gastroenterol. |
pmid:9448170
|
Sax L |
Bacterial pharyngitis in children. |
1998 |
J Fam Pract |
pmid:9451356
|
Sevin E et al. |
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. |
1998 |
FEMS Microbiol. Lett. |
pmid:9742711
|
Hiratsuka T et al. |
[Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone]. |
1998 |
Nihon Kokyuki Gakkai Zasshi |
pmid:9742869
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Lygren I et al. |
[Treatment of Helicobacter pylori infection]. |
1998 |
Tidsskr. Nor. Laegeforen. |
pmid:9889634
|
Einarson A et al. |
A prospective controlled multicentre study of clarithromycin in pregnancy. |
1998 |
Am J Perinatol |
pmid:9890248
|
Tsuneoka H et al. |
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy]. |
1998 |
Kansenshogaku Zasshi |
pmid:9621560
|
Abe M et al. |
A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. |
1998 |
Respir Med |
pmid:9893782
|
Amsden GW et al. |
Oral cimetidine prolongs clarithromycin absorption. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9660986
|
Spinzi GC et al. |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663722
|
Warheker PT et al. |
Successful treatment of saccular endophthalmitis with clarithromycin. |
1998 |
Eye (Lond) |
pmid:10326009
|
Bazzoli F et al. |
Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663723
|
Pozzato P et al. |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663724
|
Bocheńska-Marciniak M et al. |
[Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections]. |
1998 |
Pol. Arch. Med. Wewn. |
pmid:10335027
|
Griffith DE |
Mycobacteria as pathogens of respiratory infection. |
1998 |
Infect. Dis. Clin. North Am. |
pmid:9779380
|
Casswall TH et al. |
One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection. |
1998 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:9779970
|
Aberg JA et al. |
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. |
1998 |
J. Infect. Dis. |
pmid:9780266
|
Hahn DL et al. |
Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. |
1998 |
Ann. Allergy Asthma Immunol. |
pmid:9475566
|
Sonnenberg A et al. |
Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. |
1998 |
Arch. Intern. Med. |
pmid:9570170
|
Dal Bo' N et al. |
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks? |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9570242
|
O'Connor HJ et al. |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough? |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9570262
|
Scott BB |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9570263
|
Jarboe E et al. |
Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9572027
|
Treiber G et al. |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. |
1998 |
Helicobacter |
pmid:9546119
|
Preston SL et al. |
Drug interactions in HIV-positive patients initiated on protease inhibitor therapy. |
1998 |
AIDS |
pmid:9468380
|
Suzuki J et al. |
Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan. |
1998 |
Helicobacter |
pmid:9546120
|
Lindsetmo RO et al. |
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy. |
1998 |
Scand. J. Gastroenterol. |
pmid:9548613
|
Comet R et al. |
[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection]. |
1998 |
Gastroenterol Hepatol |
pmid:9549183
|
Carnicer J |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?]. |
1998 |
Gastroenterol Hepatol |
pmid:9549199
|
Kato S et al. |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. |
1998 |
Helicobacter |
pmid:9844069
|
Gisbert JP et al. |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?]. |
1998 |
Rev Clin Esp |
pmid:9844453
|
Gisbert JP et al. |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori]. |
1998 |
Rev Clin Esp |
pmid:9844458
|
Gudjonsson H et al. |
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9845401
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
Kaeser YA et al. |
Severe hypotension and bradycardia associated with verapamil and clarithromycin. |
1998 |
Am J Health Syst Pharm |
pmid:9825040
|
Sakamoto M et al. |
[Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer]. |
1998 |
Jpn J Antibiot |
pmid:9597485
|
Teramoto S et al. |
[Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer]. |
1998 |
Jpn J Antibiot |
pmid:9597486
|
Ueta K et al. |
[Evaluation of BRM (biological response modifier) action of clarithromycin (CAM)--effect on cytokine expression in a mouse lung cancer model]. |
1998 |
Jpn J Antibiot |
pmid:9597487
|
Kokubo Y et al. |
[Effect of clarithromycin on experimental pulmonary metastasis]. |
1998 |
Jpn J Antibiot |
pmid:9597488
|
Yano S et al. |
[Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system]. |
1998 |
Jpn J Antibiot |
pmid:9597491
|
Sasa K et al. |
[Antineoplastic therapeutic effect of clarithromycin in rats]. |
1998 |
Jpn J Antibiot |
pmid:9597492
|
Miyamoto N et al. |
[Test to set dosages for long-term administration of clarithromycin to treat chronic paranasal sinusitis]. |
1998 |
Jpn J Antibiot |
pmid:9597498
|
Perng CL et al. |
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. |
1998 |
Dig. Dis. Sci. |
pmid:9539638
|
Fujita K et al. |
[Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics]. |
1998 |
Jpn J Antibiot |
pmid:9597505
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Scheen AJ |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. |
1998 |
Rev Med Liege |
pmid:9555183
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Cheng KL et al. |
Effect of grapefruit juice on clarithromycin pharmacokinetics. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559810
|
Goujard C et al. |
Clarithromycin-resistant Mycobacterium avium strain in a clarithromycin-naive AIDS patient. |
1998 |
Clin. Infect. Dis. |
pmid:9455532
|
Williamson R et al. |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. |
1998 |
Scand. J. Gastroenterol. Suppl. |
pmid:9515751
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Adamek RJ et al. |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome. |
1998 |
Am. J. Gastroenterol. |
pmid:9517645
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9517944
|
Sheu BS et al. |
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy. |
1998 |
J. Formos. Med. Assoc. |
pmid:9585678
|
Hasegawa M et al. |
[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates]. |
1998 |
Kansenshogaku Zasshi |
pmid:9585692
|
Carr RA et al. |
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593146
|
Sörberg M et al. |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593154
|
Roussel G and Igual J |
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries. |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9626603
|
Archimandritis A et al. |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. |
1998 |
J. Intern. Med. |
pmid:9627163
|
Howden CW and Hunt RH |
Treating Helicobacter pylori. |
1998 |
Arch. Intern. Med. |
pmid:9827792
|
Petersen AM et al. |
[Resistance of Helicobacter pylori to clarithomycin]. |
1998 |
Ugeskr. Laeg. |
pmid:9627511
|
Domingo D et al. |
High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. |
1998 |
J. Antimicrob. Chemother. |
pmid:9630414
|
Holmberg SD et al. |
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. |
1998 |
JAMA |
pmid:9459473
|
Wakasugi H et al. |
Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9695727
|
Hsieh PF et al. |
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. |
1998 |
J. Formos. Med. Assoc. |
pmid:9700240
|
Ellenrieder V et al. |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9701524
|
Burman WJ et al. |
AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9635911
|
Nordt SP et al. |
Clarithromycin induced digoxin toxicity. |
1998 |
J Accid Emerg Med |
pmid:9639187
|
Gray VS |
Syncopal episodes associated with cisapride and concurrent drugs. |
1998 |
Ann Pharmacother |
pmid:9640482
|
Grove DI et al. |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. |
1998 |
Pathology |
pmid:9643503
|
Makhani S et al. |
Atypical cervico-facial mycobacterial infections in childhood. |
1998 |
Br J Oral Maxillofac Surg |
pmid:9643597
|